Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6906693 | 1.00 | NPC1 (0.32) | NPC1HPGDMAPK1HTTRAB9A | |
| Hydrochloric Acid SCHEMBL28051360 | 0.96 | NPC1 (0.31) | NPC1HPGDMAPK1HTTRAB9A | |
| Hydrochloric Acid SCHEMBL8577642 | 0.96 | NPC1 (0.31) | NPC1HPGDMAPK1HTTRAB9A | |
| SCHEMBL7575488 | 0.89 | — | — | |
| SCHEMBL6254543 | 0.86 | — | — | |
| SCHEMBL1025348 | 0.78 | NPC1 (0.32) | NPC1HPGDMAPK1HTTRAB9A | |
| SCHEMBL11022343 | 0.77 | — | — | |
| SCHEMBL6252137 | 0.77 | — | — | |
| SCHEMBL1753874 | 0.76 | — | — | |
| SCHEMBL7624298 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013158411-A1 | METHODS OF SEPARATING COMPOUNDS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-10-24 | — | — | WO | disclosed |
| US-20130276519-A1 | Methods of Separating Compounds | EXXONMOBIL CHEMICAL PATENTS INC. | 2013-10-24 | — | — | US | disclosed |
| US-20030216590-A1 | Novel dendrimer compounds, method for the production thereof, use thereof as catalysts | BECKE SIGURD (DE) | 2003-11-20 | — | — | US | disclosed |
| US-6570031-B1 | Addition polymerization catalyst | BAYER AKTIENGESELLSCHAFT (DE) | 2003-05-27 | — | — | US | disclosed |
| EP-1066296-B1 | NOVEL DENDRIMER COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS CATALYSTS | BAYER AG (DE) | 2002-09-04 | — | — | EP | disclosed |
| US-6403735-B1 | REACTING TRANSITION METAL COMPOUND WITH FULVENE COMPOUND IN PRESENCE OF REDUCING AGENT | BAYER AKTIENGESELLSCHAFT (DE) | 2002-06-11 | — | — | US | disclosed |
| US-20020010084-A1 | Method for producting fulvene metal complexes | BECKE SIGURD (DE) | 2002-01-24 | — | — | US | disclosed |
| US-6258744-B1 | OLEFIN POLYMERIZATION CATALYST | BAYER AKTIENGESELLSCHAFT (DE) | 2001-07-10 | — | — | US | disclosed |
| EP-1063243-A2 | Olefin polymerization process and catalyst system therefor | BAYER AG (DE) | 2000-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216590-A1 | Novel dendrimer compounds, method for the production thereof, use thereof as catalysts | COASY, CDIPT, FDFT1 | NPC1 1129/4885HPGD 358/4885MAPK1 4623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.